- Home
- GIPR vs GCTK Comparison
GIPR vs GCTK Comparison
Compare GIPR & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIPR | GCTK |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GIPR | GCTK |
|---|---|---|
| Price | $0.95 | $5.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 702.2K | 20.4K |
| Earning Date | 11-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,953,920.00 | N/A |
| Revenue This Year | $1.12 | N/A |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.78 | $4.22 |
| 52 Week High | $2.06 | $468.00 |
Technical Indicators
Market Signals| Indicator | GIPR | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 45.65 | 48.20 |
| Support Level | $0.89 | $5.53 |
| Resistance Level | $1.34 | $6.71 |
| Average True Range (ATR) | 0.14 | 0.46 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 26.44 | 45.83 |
Price Performance
Historical ComparisonAbout GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.